ASX:ACL   AUSTRALIAN CLINICAL LABS LIMITED
Text me if you have any questions/comments for me.

-----

ACL
- First time doing a written analysis on ACL
- Recently IPO-ed stock in mid-May – Has had some uptrends
- Had some obvious retracement around 4.60 levels
- Recently tested the short-term support and today, rebounded from there
- A successful rebound would see the stock rise above the resistance of 4.60 levels
- R is less than 10%
- Strategy-to-buy (DYOR) – Suggest waiting successful rebound before plotting entry

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。